missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ LTGO-33
Description
LTGO-33 is a potent and selective state-independent inhibitor of NaV1.8 sodium channels (IC50 = 13 nM for the closed state; IC50 = 24 nM for the inactive state). It displays 600-fold selectivity over other sodium channels such as NaV1.1-1.7 and NaV1.9. By binding to NaV1.8 channels, LTGO-33 inhibits action potential initiation and transmission of pain signals in human DRG neurons. Unlike other NaV1.8 inhibitors that preferentially interact with an inactivated state via the pore region, LTGO-33 is state-independent with similar potencies against closed and inactivated channels.
Specifications
Specifications
| Chemical Name or Material | (R)-2-(4-Fluoro-2-methylphenoxy)-N-(3-(S-methylsulfonimidoyl)phenyl)-5-(trifluoromethyl)nicotinamide |
| CAS | 2834106-06-6 |
| Quantity | 50 mg |
| Product Line | Tocris |
| Target | Voltage-gated Sodium Channel Inhibitors |
| Molecular Formula | C21H17F4N3O3S |
| Purity | 98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?